Dr. Melissa M. Rooney, MD

Dr. Rooney practices at Missouri Baptist Medical Center in Saint Louis, Missouri, part of BJC Health.

Dr. Rooney's NPI, 1659577047, was assigned on June 22, 2007. Dr. Rooney graduated from Loyola University of Chicago, Stritch School of Medicine in 2007. Dr. Rooney holds Missouri license 2010024534.

Dr. Rooney's primary practice is Missouri Baptist Medical Center, at 3015 N Ballas Rd, Saint Louis, MO 63131 in St. Louis County. The practice phone is (314) 996-5000.

Dr. Rooney's primary practice is Missouri Baptist Medical Center in Saint Louis, Missouri, part of BJC Health. Dr. Rooney is also affiliated with Barnes-Jewish Hospital. The medical group on file is Missouri Baptist Medical Center. Dmand AI also links Dr. Rooney to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rooney practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Rooney's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Rooney is licensed in Missouri.

CMS data shows 794 Medicare services from Dr. Rooney across 9 procedure codes in 2024, for 298 Medicare patients. Medicare paid $59,534 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 298 Medicare patients who saw Dr. Rooney in 2024. The largest group is 65 to 74, with 147 patients. 71% of them have cancer, and 68% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rooney's median patient age at 73, with 87% women.

In 2024, Dr. Rooney wrote 1,584 Medicare Part D claims for 305 patients. 89% of them were for generic drugs. CMS names the drug for 1,310 of them, across 24 drugs with 11 or more claims each, at $1,016,163 in total drug cost. In 2023, CMS named 1,346 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Rooney for performance year 2024, reported as part of a group. Dr. Rooney accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Rooney, published from 2013 to 2022. 2013 was the busiest year, with 2. The most frequent topics are Adenocarcinoma, Carcinoma, Non-Small-Cell Lung and Genomics. Dr. Rooney's most frequent co-authors are Siddhartha Harish Krishna Devarakonda, MD, Boone W. Goodgame, MD and Kan Huang, MD.

CMS Open Payments shows 206 general payments to Dr. Rooney from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Novartis Pharmaceuticals Corporation paid the most, $433.

Dr. Rooney graduated from Loyola University of Chicago, Stritch School of Medicine in 2007.